Psychiatry Research: Neuroimaging
Volume 154, Issue 3 , Pages 259-265 , 15 April 2007

Reduced concentrations of N-acetylaspartate (NAA) and the NAA–creatine ratio in the basal ganglia in bipolar disorder: A study using 3-Tesla proton magnetic resonance spectroscopy

  • Mark A. Frye

      Affiliations

    • Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
    • Corresponding Author InformationCorresponding author. Mayo Clinic, Department of Psychiatry, 200 First Street, SW, Rochester, MN 55905, USA. Tel.: +1 507 255 1475; fax: +1 507 255 9416.
    • ,
  • M. Albert Thomas

      Affiliations

    • Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
    • Department of Radiological Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
    • ,
  • Kenneth Yue

      Affiliations

    • Department of Radiological Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
    • ,
  • Nader Binesh

      Affiliations

    • Department of Radiological Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
    • ,
  • Pablo Davanzo

      Affiliations

    • Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
    • ,
  • Joseph Ventura

      Affiliations

    • Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
    • ,
  • Joseph O'Neill

      Affiliations

    • Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
    • ,
  • Barry Guze

      Affiliations

    • Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
    • ,
  • John G. Curran

      Affiliations

    • Department of Radiological Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
    • ,
  • Jim Mintz

      Affiliations

    • Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA

Received 3 August 2005 ,Revised 19 July 2006 ,Accepted 21 November 2006.

References 

  1. Altshuler LL. Bipolar disorder: are repeated episodes associated with neuroanatomic and cognitive changes?. Biological Psychiatry. 1993;33:563–565
  2. Baslow MH. N-acetylaspartate in the vertebrate brain: metabolism and function. Neurochemistry Research. 2003;28:941–953
  3. Bertolino A, Frye M, Callicott JH, Mattay VS, Rakow R, Shelton-Repella J, et al. Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imaging. Biological Psychiatry. 2003;53:906–913
  4. Blasi G, Bertolino A, Budaglio F, Sciota D, Altamora M, Antonucci N, et al. Hippocampal neurochemcial pathology in patients at first episode of affective psychosis: a proton magnetic resonance spectroscopic imaging study. Psychiatry Research Neuroimaging. 2004;131:95–105
  5. Brambilla P, Stanley JA, Nicoletti MA, Sassi RB, Mallinger AB, Frank E, et al. 1H magnetic resonance spectroscopy investigation of the dorsolateral prefrontal cortex in bipolar disorder patients. Journal of Affective Disorders. 2005;86:61–67
  6. Buchsbaum MS, Wu J, DeLisi LE, Holcomb H, Kessler R, Johnson J, et al. Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness. Journal of Affective Disorders. 1986;10:137–152
  7. Callicott JH, Bertolino A, Mattay VS, Langheim FJP, Weinberger DR. Selective relationship between NAA measure and negative symptoms in schizophrenia. American Journal of Psychiatry. 2000;157:1646–1651
  8. Cecil KM, Del Bello MP, Morey R, Strakowski SM. Frontal lobe differences in bipolar disorder as determined by proton MR spectroscopy. Bipolar Disorders. 2002;4:357–365
  9. Cecil KM, Del Bello MP, Sellars MC, Strakowski SM. Proton magnetic resonance spectroscopy of the frontal lobe and cerebellar vermies in children with a mood disorder and a familial risk for bipolar disorder. Journal of Child and Adolescent Psychopharmacology. 2003;13:545–555
  10. Chang K, Adleman N, Dienes K, Barnea-Goraly N, Reiss A, Ketter T. Decreased N-acetylaspartate in children with familial bipolar disorder. Biological Psychiatry. 2003;53:1059–1065
  11. Davanzo P, Thomas MA, Yue K, Oshiro T, Belin T, Strober M, et al. Decreased anterior cingulate myo-inositol/creatine spectroscopy resonance with lithium treatment in children with bipolar disorder. Neuropsychopharmacology. 2001;24:359–369
  12. Deicken RF, Eliaz Y, Feiwell R, Schuff N. Increased thalamic N-acetylaspartate in male patients with familial bipolar I disorder. Psychiatry Research: Neuroimaging. 2001;106:35–45
  13. Deicken RF, Pegues MP, Anzalone S, Feiwell R, Soher B. Lower concentration of hippocampal N-acetylaspartate in familial bipolar I disorder. American Journal of Psychiatry. 2003;160:873–882
  14. Demougeot C, Garnier P, Mossiat C, Betrand N, Giroud M, Beley A, et al. N-acetylaspartate, a marker of both cellular dysfunction and neuronal loss: its relevance to studies of acute brain injury. Journal of Neurochemistry. 2001;77:408–415
  15. Drevets WC, Raichle ME. Neuroanatomical circuits in depression: implications for treatment mechanisms. Psychopharmacology Bulletin. 2002;28:261–274
  16. Dupont RM, Jernigan TL, Butters N, Delis D, Hesselink JR, Heindel W, et al. Subcortical abnormalities detected in bipolar disorder using magnetic resonance imaging. Archives of General Psychiatry. 1990;47:55–59
  17. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders, Research Version, Patient Edition (SCID-I/P). New York, NY: Biometrics Research, New York State Psychiatric Institute; 1997;
  18. Frahm J, Bruhn H, Gyngell ML, Merboldt KD, Hanicke W, Sauter R. Localized high-resolution proton NMR spectroscopy using stimulated echoes; initial applications to human brain in vivo. Magnetic Resonance in Medicine. 1989;9:79–93
  19. Haase A, Frahm J, Hänicke W, Matthaei D. 1H NMR chemical shift selective (CHESS) imaging. Physics in Medicine and Biology. 1985;30:341–344
  20. Hamakawa H, Kato T, Murashita J, Kato N. Quantitative proton magnetic resonance spectroscopy of the basal ganglia in patients with affective disorders. European Archives of Psychiatry and Clinical Neuroscience. 1998;248:53–58
  21. Kato T, Hamakawa H, Shioiri T, Murashita J, Takahashi Y, Takahashi S, et al. Choline-containing compounds detected by proton magnetic resonance spectroscopy in the basal ganglia in bipolar disorder. Psychiatric Neuroscience. 1996;21:248–254
  22. Mai JK, Assheuer J, Paxinos G. In: Atlas of the Human Brain. vol. viii:San Diego: Academic Press; 1997;p. 328
  23. Mega MS, Cummings JL. Frontal–subcortical circuits and neuropsychiatric disorders. Journal of Neuropsychiatry and Clinical Neuroscience. 1994;6:358–370
  24. Moore GJ, Galloway M. Magnetic resonance spectroscopy: neurochemistry and treatment effects in affective disorders. Psychopharmacology Bulletin. 2002;36:5–23
  25. Moore GJ, Bebchuck JM, Wilds IB, Chen G, Manji HK. Lithium-induced increase in human brain grey matter. Lancet. 2000;356:1241–1242
  26. Ohara K, Isoda H, Suziki Y, Takehara Y, Ochiai M, Takeda H, et al. Proton magnetic resonance spectroscopy of the lenticular nuclei in bipolar I affective disorder. Psychiatry Research: Neuroimaging. 1998;84:55–60
  27. Ongur D, Drevets EWC, Price JL. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proceedings of the National Academy of Sciences of the United States of America. 1998;95:13290–13295
  28. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magnetic Resonance in Medicine. 1993;30:672–679
  29. Provencher SW. Automatic quantitation of localized in vivo 1H spectra with LC Model. NMR in Biomedicine. 2001;14:260–264
  30. Rajkowska G, Halaris A, Selemon LD. Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder. Biological Psychiatry. 2001;49:741–752
  31. Sharma R, Venkatasubramanian PN, Bárány M, Davis JM. Proton magnetic resonance spectroscopy of the brain in schizophrenic and affective patients. Schizophrenia Research. 1992;8:42–43
  32. Silverstone PH, Wu RH, O'Donnell T, Ulrich M, Asghar SJ, Hanstock CC. Chronic treatment with lithium, but not sodium valproate, increases cortical N-acetylaspartate concentrations in euthymic bipolar patients. International Clinical Psychopharmacology. 2003;18:73–79
  33. Soares JC, Mann JJ. The functional neuroanatomy of mood disorders. Journal of Psychiatric Research. 1997;31:393–432
  34. Stanley JA. In vivo magnetic resonance spectroscopy and its application to neuropsychiatric disorders. Canadian Journal of Psychiatry. 2002;47:315–326
  35. Stoll A, Renshaw PF, Yurgelun-Todd DA, Cohen BM. Neuroimaging in bipolar disorder: what have we learned?. Biological Psychiatry. 2000;48:505–517
  36. Strakowski SM, DelBello MP, Adler CM. The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings. Molecular Psychiatry. 2005;10:105–116
  37. Tsai G, Coyle JT. N-acetylaspartate in neuropsychiatric disorders. Progress in Neurobiology. 1995;46:531–540
  38. Winsberg ME, Sachs N, Tate DL, Adalsteinsson E, Spielman D, Ketter TA. Decreased dorsolateral prefrontal N-acetylaspartate in bipolar disorder. Biological Psychiatry. 2000;47:475–481
  39. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. British Journal of Psychiatry. 1978;133:429–435

PII: S0925-4927(06)00199-5

doi: 10.1016/j.pscychresns.2006.11.003

Psychiatry Research: Neuroimaging
Volume 154, Issue 3 , Pages 259-265 , 15 April 2007

Article Tools

* Image Usage & Resolution